Vincent Rajkumar, MD
vincentrk.bsky.social
Vincent Rajkumar, MD
@vincentrk.bsky.social
Editor in Chief, Blood Cancer Journal; Professor, Mayo Clinic; Associate Editor, Mayo Clinic Proceedings; Oncologist, Cancer Research, Myeloma.
Pinned
Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM

5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...
Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM

5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...
October 18, 2025 at 12:57 PM
Reposted by Vincent Rajkumar, MD
So excited to see this thread on BlueSky, @vincentrk.bsky.social! Thank you as always for your excellent summaries!
My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24
#ASH24VR

1. Newly diagnosed transplant ineligible. Quadruplet unless frail. Maintenance varies by risk stratification.
December 9, 2024 at 5:52 PM
Wow. I’m overwhelmed by the response here. Will post more on here.
December 22, 2024 at 11:35 PM
My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24
#ASH24VR

1. Newly diagnosed transplant ineligible. Quadruplet unless frail. Maintenance varies by risk stratification.
December 8, 2024 at 3:56 PM
My first post here.

Holy cow! And I already have followers here! Thanks so much everyone.

I’m still trying to figure out how to post on X and here.
#ASH24
December 8, 2024 at 12:11 AM